Synapse - Center for Hematologic Malignancies

Search Within

Center for Hematologic Malignancies

Results (13544)

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Journal Article

Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
Blood Neoplasia (2024)

Fulltext@MSK | Save

Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination

Journal Article

Shyamsundar, S.; Pierson, S. K.; Connolly, C. M.; Teles, M.; Segev, D. L.; Werbel, W. A.; van Rhee, F.; Casper, C.; Brandstadter, J. D.; Noy, A.; more...
Blood Neoplasia (2024)

Fulltext@MSK | Save

Machine learning in cancer-associated thrombosis: Hype or hope in untangling the clot

Review

Patell, R.; Zwicker, J. I.; Singh, R.; Mantha, S.
Bleeding, Thrombosis and Vascular Biology (2024)

Fulltext@MSK | Save

A phase 1 study of avapritinib in combination with decitabine in patients with systemic mastocytosis with an associated hematologic neoplasm

Meeting Abstract

Kuykendall, A. T.; Ball, S.; Gotlib, J.; Yi, C. Y. A.; Tashi, T.; Rampal, R.; DeAngelo, D. J.; Volpe, V. O.; Pettit, K. M.; Hoehn, G.; more...
Blood (2024)

Fulltext@MSK | Save

CTEP 10590, NORM: Nodular lymphocyte predominant Hodgkin lymphoma patients treated in a randomized phase II trial with either rituximab or mosunetuzumab

Meeting Abstract

Steiner, R.; Bock, A. M.; Herrera, A. F.; Zulfa, O.; Hoffmann, M.; Ibrahimi, S.; Galanina, N.; Lee, H. J.; Green, M.; Lin, R.; more...
Blood (2024)

Fulltext@MSK | Save

OPTIMIZE: A phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation

Meeting Abstract

Auletta, J. J.; Devine, S. M.; Stefanski, H. E.; Spellman, S. R.; Defor, T. E.; Logan, B. R.; Butler, B. J.; Gooptu, M.; Shaffer, B. C.; Jimenez, A. M. J.; more...
Blood (2024)

Fulltext@MSK | Save

CD38-SADA pretargeted radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in adult patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human phase 1 trial

Meeting Abstract

Zain, J.; Wong, J.; Horwitz, S.; Pandit-Taskar, N.; Al-Janadi, A.; Mancini, B.; Khawaja, R.; Lee, C. Y.; Howansky, A.; Liles, D.; more...
Blood (2024)

Fulltext@MSK | Save

A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)

Meeting Abstract

Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
Blood (2024)

Fulltext@MSK | Save

A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or Dara-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis

Meeting Abstract

Hagen, P.; Sidana, S.; Parker, T. L.; Walker, B. A.; Sanchorawala, V.; Zonder, J. A.; Kourelis, T.; D'Souza, A.; Landau, H. J.; Rosenthal, A.; more...
Blood (2024)

Fulltext@MSK | Save

Results from the Great Britain AML real world evidence (ARC) initiative - A centre-based chart review study to assess treatment outcomes of venetoclax for the treatment of acute myeloid leukemia

Meeting Abstract

O'Nions, J.; Errico, G.; Floro, L.; Murthy, V.; Sweeney, C.; Kaur, H.; Mohite, U.; Ayto, R.; Alvares, C.; Goldberg, A. D.; more...
Blood (2024)

Fulltext@MSK | Save